UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 31, 2016
Kewaunee Scientific Corporation
(Exact name of registrant as specified in its charter)
| Delaware | 0-5286 | 38-0715562 | ||
| (State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(IRS Employer Identification No.) |
2700 West Front Street
Statesville, NC 28677
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (704) 873-7202
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 5.07. | Submission of Matters to a Vote of Security Holders. |
| (a) and (b) | On August 31, 2016, the Company held its 2016 Annual Meeting of Stockholders. At that meeting, the Company’s shareholders voted on the matters set forth below. |
| 1. | Each of the nominees named below was re-elected as a Class III director for a three year term as follows: |
| Name of Nominee |
For | Withheld | Non-Votes | |||||||||
| Margaret B. Pyle |
1,833,400 | 22,989 | 595,671 | |||||||||
| Donald F. Shaw |
1,783,000 | 73,389 | 595,671 | |||||||||
| 2. | The independent registered accounting firm of Ernst & Young LLP was ratified as the Company’s independent auditor for fiscal year 2017 as follows: |
| For |
Against |
Abstained | ||
| 2,444,167 |
5,604 | 2,289 |
| 3. | The compensation of the Company’s named executive officers was approved on an advisory basis pursuant to the following votes: |
| For |
Against |
Abstained |
Non-Votes | |||
| 1,776,368 |
73,200 | 6,821 | 595,671 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: September 2, 2016
| Kewaunee Scientific Corporation | ||
| By: | /s/ Thomas D. Hull III | |
| Thomas D. Hull III | ||
| Vice President, Finance and | ||
| Chief Financial Officer | ||